Impact of emerging pollutants on pulmonary inflammation in asthmatic rats: Ethanol vapors and agglomerated TiO2 nanoparticles

Inhalation Toxicology

Volumn 24, Issue 8, 2012, Pages 528-538

  Scarino, A ^a   Noel A ^b   Renzi, P M ^c   Cloutier, Y ^d   Vincent, R ^e   Truchon, G ^d   Tardif, R ^b   Charbonneau, M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d INSTITUT DE RECHERCHE ROBERT SAUVÉ EN SANTÉ ET EN SÉCURITÉ DU TRAVAIL   (Canada)

^e Environmental Health Center   (Canada)

Author keywords

Asthma; Eosinophils; Ethanol; Lung inflammation; Nanoparticules; Ovalbumin; TiO2

Indexed keywords

ALCOHOL; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; NANOPARTICLE; OVALBUMIN; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

AIR POLLUTION; ANIMAL EXPERIMENT; ARTICLE; ASTHMA; CONTROLLED STUDY; FEMALE; HISTOLOGY; LEUKOCYTE; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AEROSOLS; AIR POLLUTANTS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; INHALATION EXPOSURE; LUNG; MALE; NANOPARTICLES; OVALBUMIN; PNEUMONIA; RATS; RATS, INBRED BN; TITANIUM; VOLATILIZATION;

RATTUS; RATTUS NORVEGICUS;

EID: 84863330423     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.696741     Document Type: Article

References (63)

1. Arif AA, Shah SM. 2007. Association between personal exposure to volatile organic compounds and asthma among US adult population. Int Arch Occup Environ Health 80:711-719. (Pubitemid 46881735)
2. Baggs RB, Ferin J, Oberdörster G. 1997. Regression of pulmonary lesions produced by inhaled titanium dioxide in rats. Vet Pathol 34:592-597. (Pubitemid 27505679)
3. Ban M, Morel G, Langonné I, Huguet N, Pépin E, Binet S. 2006. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 218:39-47. (Pubitemid 41774670)
4. Bermudez E, Mangum JB, Asgharian B, Wong BA, Reverdy EE, Janszen DB, Hext PM, Warheit DB, Everitt JI. 2002. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 70:86-97. (Pubitemid 35331794)
5. Chen X, Mao SS. 2007. Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications. Chem Rev 107:2891-2959. (Pubitemid 47162903)
6. Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, Megson IL, Donaldson K. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 118:1699-1706.
7. de Haar C, Hassing I, Bol M, Bleumink R, Pieters R. 2006. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Allergy 36:1469-1479. (Pubitemid 44674132)
8. Dong CC, Yin XJ, Ma JY, Millecchia L, Barger MW, Roberts JR, Zhang XD, Antonini JM, Ma JK. 2005. Exposure of Brown Norway rats to diesel exhaust particles prior to ovalbumin (OVA) sensitization elicits IgE adjuvant activity but attenuates OVA-induced airway inflammation. Toxicol Sci 88:150-160. (Pubitemid 41548757)
9. El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC. 2006. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol 6:1135-1142. (Pubitemid 43728167)
10. Elwood W, Lötvall JO, Barnes PJ, Chung KF. 1991. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol 88:951-960.
11. Fujimura M, Myou S, Kamio Y, Ishiura Y, Iwasa K, Hashimoto T, Matsuda T. 1999. Increased airway responsiveness to acetaldehyde in asthmatic subjects with alcohol-induced bronchoconstriction. Eur Respir J 14:19-22. (Pubitemid 29411229)
12. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 38:371-376. (Pubitemid 351567707)
13. Grassian VH, O'shaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS. 2007. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Health Perspect 115:397-402. (Pubitemid 46554438)
14. Health Canada. 2010. Ethanol benefits. [online] Available at:http://oee.nrcan.gc.ca/transportation/alternative-fuels/fuel-facts/ethanol/ benefits.cfm?attr=16 Accessed on 13 February 2012.
15. Hinds WC. 1999. Aerosol technology, properties, behavior and measurement of airborne particles. New York: John Wiley & sons inc.
16. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, Martens JA, Dinsdale D, Boland S, Marano F, Nemery B, Hoet PH. 2011. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37:299-309.
17. Jacobsen NR, Møller P, Jensen KA, Vogel U, Ladefoged O, Loft S, Wallin H. 2009. Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/-mice. Part Fibre Toxicol 6:2.
18. Jiang J, Oberdörster G, Elder A, Gelein R, Mercer P, Biswas P. 2008. Does Nanoparticle Activity Depend upon Size and Crystal Phase? Nanotoxicology 2:33-42.
19. Larsen ST, Roursgaard M, Jensen KA, Nielsen GD. 2010. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol 106:114-117.
20. Lukacs NW, Hogaboam CM, Kunkel SL, Chensue SW, Burdick MD, Evanoff HL, Strieter RM. 1998. Mast cells produce ENA-78, which can function as a potent neutrophil chemoattractant during allergic airway inflammation. J Leukoc Biol 63:746-751. (Pubitemid 28274837)
21. Lux Research. 2006. Nanotech Report, 4th ed. The indispensable reference guide to nanotechnology. www.luxresearchinc.com/press/RELEASE-TNR4.pdf
22. Ma-Hock L, Gamer AO, Landsiedel R, Leibold E, Frechen T, Sens B, Linsenbuehler M, van Ravenzwaay B. 2007. Generation and characterization of test atmospheres with nanomaterials. Inhal Toxicol 19:833-848. (Pubitemid 47237751)
23. Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, van Ravenzwaay B, Landsiedel R. 2009. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal Toxicol 21:102-118.
24. Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299-319.
25. Morrow PE. 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 10:369-384. (Pubitemid 18097027)
26. Mühlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. 2008. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 294:L817-L829.
27. Murr LE, Esquivel EV, Bang JJ. 2004. Characterization of nanostructure phenomena in airborne particulate aggregates and their potential for respiratory health effects. J Mater Sci Mater Med 15:237-247. (Pubitemid 38388821)
28. Myou S, Fujimura M, Nishi K, Ohka T, Matsuda T. 1993. Aerosolized acetaldehyde induces histamine-mediated bronchoconstriction in asthmatics. Am Rev Respir Dis 148:940-943. (Pubitemid 23301210)
29. Myou S, Fujimura M, Nishi K, Watanabe K, Matsuda M, Ohka T, Matsuda T. 1996. Effect of ethanol on airway caliber and nonspecific bronchial responsiveness in patients with alcohol-induced asthma. Allergy 51:52-55. (Pubitemid 26104696)
30. Oberdörster G. 1988. Lung clearance of inhaled insoluble and soluble particles. J Aerosol Med 1:289-329.
31. Oberdörster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102 SUPPL. 5:173-179. (Pubitemid 24364846)
32. Oberdörster G, Cox C, Gelein R. 1997. Intratracheal instillation versus intratracheal-inhalation of tracer particles for measuring lung clearance function. Exp Lung Res 23:17-34. (Pubitemid 27065382)
33. Oberdörster G. 2001. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 74:1-8. (Pubitemid 32123735)
34. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
35. Parkinson A. 2001. Biotransformation of xenobiotics. In: Klaassen CD (ed.) Casarett and Doull's toxicology. The basic science of poisons, 6th ed., New York: McGraw-Hill. pp. 152-156.
36. Pauluhn J, Mohr U. 2000. Inhalation studies in laboratory animals-current concepts and alternatives. Toxicol Pathol 28:734-753.
37. Pauluhn J. 2005. Overview of inhalation exposure techniques: strengths and weaknesses. Exp Toxicol Pathol 57 SUPPL. 1:111-128. (Pubitemid 40894634)
38. Pauluhn J. 2009. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 109:152-167.
39. Persson CG, Uller L. 2010. Resolution of cell-mediated airways diseases. Respir Res 11:75.
40. Renzi PM, Sapienza S, Waserman S, Du T, Olivenstein R, Wang NS, Martin JG. 1992. Effect of interleukin-2 on the airway response to antigen in the rat. Am Rev Respir Dis 146:163-169.
41. Renzi PM, Olivenstein R, Martin JG. 1993. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Respir Dis 147:967-974. (Pubitemid 23093825)
42. Rossi EM, Pylkkänen L, Koivisto AJ, Nykäsenoja H, Wolff H, Savolainen K, Alenius H. 2010. Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model. Part Fibre Toxicol 7:35.
43. Rumchev K, Spickett J, Bulsara M, Phillips M, Stick S. 2004. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax 59:746-751. (Pubitemid 39215369)
44. Scarino A, Tardif R, Charbonneau M. 2009. Influence of ALDH2 polymorphism on ethanol kinetics and pulmonary effects in male and female rats exposed to ethanol vapors. Inhal Toxicol 21:193-199.
45. Shahzad M, Yang X, Raza Asim MB, Sun Q, Han Y, Zhang F, Cao Y, Lu S. 2009. Black seed oil ameliorates allergic airway inflammation by inhibiting T-cell proliferation in rats. Pulm Pharmacol Ther 22:37-43.
46. Siegel PD, Saxena RK, Saxena QB, Ma JK, Ma JY, Yin XJ, Castranova V, Al-Humadi N, Lewis DM. 2004. Effect of diesel exhaust particulate (DEP) on immune responses: contributions of particulate versus organic soluble components. J Toxicol Environ Health Part A 67:221-231. (Pubitemid 38125622)
47. Takao A, Shimoda T, Kohno S, Asai S, Harda S. 1998. Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype. J Allergy Clin Immunol 101:576-580. (Pubitemid 28228298)
48. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109 SUPPL. 4:547-551. (Pubitemid 32834568)
49. Takenaka S, Karg E, Kreyling WG, Lentner B, Möller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18:733-740.
50. Tardif R, Liu L, Raizenne M. 2004. Exhaled ethanol and acetaldehyde in human subjects exposed to low levels of ethanol. Inhal Toxicol 16:203-207. (Pubitemid 38470383)
51. Tesfaigzi Y, Singh SP, Foster JE, Kubatko J, Barr EB, Fine PM, McDonald JD, Hahn FF, Mauderly JL. 2002. Health effects of subchronic exposure to low levels of wood smoke in rats. Toxicol Sci 65:115-125. (Pubitemid 34092696)
52. Tesfaigzi Y, McDonald JD, Reed MD, Singh SP, De Sanctis GT, Eynott PR, Hahn FF, Campen MJ, Mauderly JL. 2005. Low-level subchronic exposure to wood smoke exacerbates inflammatory responses in allergic rats. Toxicol Sci 88:505-513. (Pubitemid 41672158)
53. Triolet. 2005. Overview of solvent usage in France at end of 2004. Hygiène et sécurité du travail-Cahiers de notes documentaires 199:65-97. [In French].
54. van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. 2009. Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz. Toxicol Lett 186:152-159.
55. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. 2007a. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171:99-110. (Pubitemid 47058824)
56. Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM. 2007b. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci 95:270-280. (Pubitemid 44942796)
57. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. 2007c. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology 230:90-104. (Pubitemid 46073330)
58. Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183-185.
59. Warheit DB. 2010. Assessing health risks of inhaled nanomaterials: development of pulmonary bioassay hazard studies. Anal Bioanal Chem 398:607-612.
60. Watanabe T. 1991. [Mechanism of ethanol-induced bronchoconstriction in Japanese asthmatic patients]. Arerugi 40:1210-1217. [In Japanese]
61. WHO. 2008. Asthma. [online]. Fact sheet N 307. Available at: http:// www.who.int/mediacentre/factsheets/fs307/en/index.html Accessed on 13 February 2012
62. Yang W, Peters JI, Williams RO 3rd. 2008. Inhaled nanoparticles-a current review. Int J Pharm 356:239-247.
63. Zuskin E, Bouhuys A, Saric M. 1981. Lung function changes by ethanol inhalation. Clin Allergy 11:243-248. (Pubitemid 11048022)